Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) on March 30, 2010. The report discloses the consolidated financial results for the fiscal year 2010 third quarter ended February 28, 2010. The specific financial data is contained in a press release attached as Exhibit 99.1, which is incorporated by reference but not included in the text of this filing.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), the content of which is not present in the provided source text.
Material Changes
The filing does not contain specific data regarding material changes versus the prior comparable period. It serves solely as a notification that the third-quarter results have been announced via a press release.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in the report and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Locate and review Exhibit 99.1 (Press Release dated March 30, 2010) to obtain actual financial figures for the quarter ended February 28, 2010.
- Confirm the fiscal quarter end date is February 28, 2010, for accurate period comparison.
- Note that the financial data in the press release is furnished and not deemed "filed" under Section 18 of the Exchange Act.